PASSAGE BIO, INC. (PASG) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $724.59M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD $-720.14M.
- 2026-03-31: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $724.07M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD $-712.32M.
- 2025-12-31: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $723.51M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD $-704.76M.
- 2025-09-30: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $722.89M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD $-691.77M.
PASSAGE BIO, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $724.59M | (m) | $-720.14M | $4.46M | 3 month · $525.00K 6 month · $1.08M |
| 2026-03-31 | (m) | $724.07M | (m) | $-712.32M | $11.75M | 3 month · $556.00K |
| 2025-12-31 | (m) | $723.51M | (m) | $-704.76M | $18.75M | 12 month · $3.00M |
| 2025-09-30 | (m) | $722.89M | (m) | $-691.77M | $31.12M | 3 month · $611.00K 9 month · $2.39M |
| 2025-06-30 | (m) | $722.28M | (m) | $-684.02M | $38.26M | 3 month · $923.00K 6 month · $1.78M |
| 2025-03-31 | $6.00K | $721.34M | (m) | $-674.64M | $46.71M | 3 month · $858.00K |
| 2024-12-31 | $6.00K | $720.49M | $8.00K | $-659.24M | $61.26M | 12 month · $5.82M |
| 2024-09-30 | $6.00K | $719.19M | $32.00K | $-646.51M | $72.72M | 3 month · $1.40M 9 month · $4.57M |
| 2024-06-30 | $6.00K | $717.79M | $-67.00K | $-627.17M | $90.56M | 3 month · $1.58M 6 month · $3.17M |
| 2024-03-31 | $6.00K | $716.12M | $-69.00K | $-611.18M | $104.88M | 3 month · $1.59M |
| 2023-12-31 | $5.00K | $705.79M | $-43.00K | $-594.47M | $111.28M | 12 month · $10.92M |
| 2023-09-30 | $5.00K | $704.17M | $-192.00K | $-577.71M | $126.28M | 3 month · $2.82M 9 month · $9.35M |
| 2023-06-30 | $5.00K | $701.35M | $-340.00K | $-550.60M | $150.41M | 3 month · $3.74M 6 month · $6.53M |
| 2023-03-31 | $5.00K | $697.52M | $-427.00K | $-526.74M | $170.35M | 3 month · $2.78M |
| 2022-12-31 | $5.00K | $694.73M | $-966.00K | $-492.41M | $201.37M | 12 month · $18.95M |
| 2022-09-30 | $5.00K | $691.19M | $-1.47M | $-465.33M | $224.40M | 3 month · $2.86M 9 month · $15.48M |
| 2022-06-30 | $5.00K | $688.25M | $-1.58M | $-438.63M | $248.05M | 3 month · $6.28M 6 month · $12.62M |
| 2022-03-31 | $5.00K | $681.73M | $-1.33M | $-399.09M | $281.31M | 3 month · $6.34M |
| 2021-12-31 | $5.00K | $675.35M | $-413.00K | $-356.28M | $318.66M | 12 month · $32.69M |
| 2021-09-30 | $5.00K | $667.32M | $33.00K | $-305.13M | $362.23M | 3 month · $6.82M 9 month · $25.12M |
| 2021-06-30 | $5.00K | $660.46M | $19.00K | $-258.21M | $402.27M | 3 month · $8.56M 6 month · $18.30M |
| 2021-03-31 | $5.00K | $651.28M | $-7.00K | $-209.78M | $441.50M | 3 month · $9.74M |
| 2020-12-31 | $4.00K | $475.62M | $-12.00K | $-170.90M | $304.71M | 12 month · $14.58M |
| 2020-09-30 | $4.00K | $470.89M | $-40.00K | $-131.95M | $338.90M | 3 month · $4.03M 9 month · $10.26M |
| 2020-06-30 | $4.00K | $466.81M | (m) | $-103.42M | $363.40M | 3 month · $3.85M 6 month · $6.22M |
| 2020-03-31 | $4.00K | $462.91M | (m) | $-76.25M | $386.67M | 3 month · $2.37M |
| 2019-12-31 | (m) | $2.41M | (m) | $-58.66M | $-56.25M | 12 month · $1.45M |
| 2019-09-30 | (m) | (m) | (m) | (m) | $-44.15M | 3 month · $95.00K 9 month · $418.00K |
| 2019-06-30 | (m) | (m) | (m) | (m) | $-32.93M | 3 month · $92.00K 6 month · $323.00K |
| 2019-03-31 | (m) | (m) | (m) | (m) | $-19.60M | 3 month · $231.00K |
| 2018-12-31 | (m) | (m) | (m) | (m) | $-12.17M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |